drugset / Trial / NCT00003856

Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy

NCT00003856 ↗

Phase 2 Unknown 75 enrolled Quintiles, Inc.
Treatment

Summary

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. This may be an effective palliative treatment for head and neck cancer. PURPOSE: Phase II trial to study the effectiveness of photodynamic therapy for palliative treatment in patients who have recurrent, refractory, or second primary head and neck cancer that cannot be treated with surgery or radiation therapy.

Timeline

Start
1998-10
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Temoporfin Other / unclassified — Intravenous

Indications